SARS-CoV2 Resources

Hier sammeln wir die für uns interessanten Veröffentlichungen und Links zum Thema. Kommentare und Hinweise schickt uns gern per Mail
Bildet Euch Eure Meinung und vergesst bitte nicht, dabei wissenschaftlich zu bleiben. Wissenschaft entwickelt sich immer weiter, was heute ein Status Quo ist, kann morgen schon durch neue Erkenntnisse widerlegt oder erweitert worden sein.

DIVI: Daten des DIVI Intensivregisters im Überblick

medRxiv: Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 (13.03.2020)

CDC: COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020 (02.04.2020)

bioRxiv: A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology (19.04.2020)

ICNARC: Report on 2249 patients critically ill with COVID-19 (04.04.2020)

medRxiv: Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: a modelling study in Hubei, China and northern Italy (30.03.2020)

CEBM: SARS-CoV-2 viral load and the severity of COVID-19 (26.03.2020)

bioRxiv: HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV (31.03.2020)

nature: Respiratory virus shedding in exhaled breath and efficacy of face masks (03.04.2020)

medRxiv: GENOMIC CHARACTERISATION AND PHYLOGENETIC ANALYSIS OF SARS-COV-2 IN ITALY (20.03.2020)

icnarc: Report on 196 patients critically ill with COVID-19

New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa2005412 (27.03.2020)

CMMID: https://cmmid.github.io/topics/covid19/severity/global_cfr_estimates.html (22.03.2020)

Science: https://science.sciencemag.org/content/367/6483/1260 (13.03.2020)

Journal of Hospital Infection: Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

ScienceDirect: Is COVID-19 receiving ADE from other coronaviruses? (12.02.2020)

Oxford Academic: On the origin and continuing evolution of SARS-CoV-2 (03.03.2020)

MedicalXpress: Preventing spread of SARS coronavirus-2 in humans (05.03.2020)

medRxiv: Adjusted age-specific case fatality ratio during the COVID-19 epidemic in Hubei, China, January and February 2020 (06.03.2020)

CMMID: Estimating the infection and case fatality ratio for COVID-19 using age-adjusted data from the outbreak on the Diamond Princess cruise ship

medRxiv: Contacts in context: large-scale setting-specific social mixing matrices from the BBC Pandemic project (05.03.2020)

CMMID: Temporal variation in transmission during the COVID-19 outbreak

THE LANCET: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? (11.03.2020)

NCBI: Features, Evaluation and Treatment Coronavirus (COVID-19) (20.03.2020)

bioRxiv: SARS-CoV-2 invades host cells via a novel route: CD147-spike protein (14.03.2020)

bioRxiv: Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak (10.03.2020)

NCBI: Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine (15.03.2012)

statista: How COVID-19 Affects Different U.S. Age Groups (19.03.2020)

medRxiv: Virus strain of a mild COVID-19 patient in Hangzhou representing a new trend in SARS-CoV-2 evolution related to Furin cleavage site (17.03.2020)

Oxford Academic: In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (09.03.2020)

Imperial College: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand (16.03.2020)

RKI: Mögliche Maßnahmen zum ressourcenschonenden Einsatz von Mund-Nasen-Schutz (MNS) und FFP-Masken in Einrichtungen des Gesundheitswesens bei Lieferengpässen im Zusammenhang mit der neuartigen Coronavirus-Erkrankung COVID-19 (13.03.2020)

nature: Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China (19.03.2020)

R Views: Simulating COVID-19 interventions with R (19.03.2020)

Taylor and Francis Online: Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes (04.02.2020)

medRxiv: A serological assay to detect SARS-CoV-2 seroconversion in humans (18.03.2020)

SSRN: Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019 (03.03.2020)

medRxiv: Age profile of susceptibility, mixing, and social distancing shape the dynamics of the novel coronavirus disease 2019 outbreak in China (20.03.2020)

CEBM: Global Covid-19 Case Fatality Rates (17.03.2020)

Cornell University: The early phase of the COVID-19 outbreak in Lombardy, Italy (20.03.2020)

medRxiv: Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial (20.03.2020)

ScienceDirect: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (18.03.2020)